@barnic,
They will jump onboard with JAT soon once they realise those biotech companies do not generate positive cashflow.
JAT is a growing company with the distribution and production infrastruture which delivers positive cashflows.
Ann: Appendix 4C - quarterly, page-54
Add JAT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.015(4.17%) |
Mkt cap ! $58.28M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 36.5¢ | 34.5¢ | $13.27K | 36.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 8948 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 9426 | 1 |
View Market Depth
| Last trade - 14.36pm 29/11/2024 (20 minute delay) ? |
| JAT (ASX) Chart |
